9 results on '"María del Val Groba Marco"'
Search Results
2. Expandiendo los nichos de donación: trasplante cardiaco de un donante con ECMO veno-venoso
- Author
-
Eduardo Caballero-Dorta, Antonio García-Quintana, María del Val Groba-Marco, José Luis Romero-Luján, Francisco Portela-Torrón, and Vicente Peña-Morant
- Subjects
Gynecology ,medicine.medical_specialty ,business.industry ,medicine ,Cardiology and Cardiovascular Medicine ,business - Published
- 2021
- Full Text
- View/download PDF
3. Spanish Heart Transplant Registry. 31th Official Report of the Heart Failure Association of the Spanish Society of Cardiology
- Author
-
Francisco González-Vilchez, Luis Almenar-Bonet, María G. Crespo-Leiro, Manuel Gómez-Bueno, José González-Costello, Félix Pérez-Villa, Juan Delgado-Jiménez, José María Arizón del Prado, José Manuel Sobrino-Márquez, Iago Sousa Casasnovas, Javier Segovia-Cubero, Francisco Hernández-Pérez, Soledad Martínez Penades, Mónica Cebrián Pinar, Raquel López Vilella, Ignacio Sánchez-Lázaro, Luis Martínez-Dolz, María J. Paniagua-Martín, Eduardo Barge-Caballero, Gonzalo Barge-Caballero, David Couto-Mallón, Amador López Granados, Carmen Segura Saintgerons, Víctor Menjíbar Pareja, Francisco Carrasco Ávalos, Manuel Cobo, Miguel Llano-Cardenal, José A. Vázquez de Prada, Francisco Nistal Herrera, Zorba Blázquez, María Jesús Valero, Carlos Ortiz, Eduardo Zataraín, Adolfo Villa, Paula Navas, Manuel Martínez-Sellés, M. Dolores García Cosío, Laura Morán Fernández, Pedro Caravaca, Vicens Brossa Loidi, Eulàlia Roig Minguell, Sonia Mirabet Pérez, Laura López López, Isabel Zegrí, Diego Rangel Sousa, Nicolas Manito Lorite, Carles Díez Lopez, Josep Roca Elias, Elena García Romero, Gregorio Rábago Juan-Aracil, María Ángeles Castel, Marta Farrero, José Luis Lambert Rodríguez, Beatriz Díaz Molina, María José Bernardo Rodríguez, Cristina Fidalgo Muñiz, Manuela Camino López, Juan Miguel Gil Jaurena, Nuria Gil Villanueva, Iris Garrido-Bravo, Domingo A. Pascual Figal, Francisco J. Pastor Pérez, Teresa Blasco-Peiró, Ana Portoles Ocampo, Marisa Sanz Julve, Luis de la Fuente Galán, Javier Tobar Ruiz, Amada Recio Platero, Luis García-Guereta Silva, Álvaro González Rocafort, Carlos Labradero de Lera, Luz Polo López, Ferrán Gran Ipiña, Dimpna C. Albert Brotons, Raúl Abella Antón, Antonio García Quintana, and María del Val Groba Marco
- Subjects
2019-20 coronavirus outbreak ,medicine.medical_specialty ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,medicine.medical_treatment ,Cardiology ,030204 cardiovascular system & hematology ,Balloon ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,medicine ,Extracorporeal membrane oxygenation ,Humans ,Registries ,Societies, Medical ,Heart transplants ,Heart transplantation ,Heart Failure ,business.industry ,General Medicine ,medicine.disease ,Spain ,Heart failure ,Circulatory system ,Heart Transplantation ,business - Abstract
Introduction and objectives The present report describes the clinical characteristics and outcomes of heart transplants in Spain and updates the data to 2019. Methods We describe the clinical characteristics and outcomes of heart transplants performed in Spain in 2019, as well as trends in this procedure from 2010 to 2018. Results In 2019, 300 transplants were performed (8794 since 1984; 2745 between 2010 and 2019). Compared with previous years, the most notable findings were the decreasing rate of urgent transplants (38%), and the consolidation of the type of circulatory support prior to transplant, with an almost complete disappearance of counterpulsation balloon (0.7%), stabilization in the use of extracorporeal membrane oxygenation (9.6%), and an increase in the use of ventricular assist devices (29.0%). Survival from 2016 to 2018 was similar to that from 2013 to 2015 (P=.34). Survival in both these periods was better than that from 2010 to 2012 (P=.002 and P=.01, respectively). Conclusions Heart transplant activity has remained stable during the last few years, as have outcomes (in terms of survival). There has been a trend to a lower rate of urgent transplants and to a higher use of ventricular assist devices prior to transplant.
- Published
- 2020
4. Flecainide Reduces Ventricular Arrhythmias in Patients With Genotype RyR2-positive Catecholaminergic Polymorphic Ventricular Tachycardia
- Author
-
María del Val Groba Marco, Josep Brugada Terradellas, Julio Salvador Hernández Afonso, Fernando Wangüemert Pérez, Eduardo Caballero Dorta, Oscar Campuzano Larrea, Luis Álvarez Acosta, Guillermo J. Pérez, and Ramón Brugada Terradellas
- Subjects
Adult ,Male ,medicine.medical_specialty ,Genotype ,DNA Mutational Analysis ,030204 cardiovascular system & hematology ,Catecholaminergic polymorphic ventricular tachycardia ,Ryanodine receptor 2 ,Electrocardiography ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Humans ,Medicine ,In patient ,030212 general & internal medicine ,Adverse effect ,Flecainide ,business.industry ,Ryanodine Receptor Calcium Release Channel ,General Medicine ,medicine.disease ,Death, Sudden, Cardiac ,Anesthesia ,Mutation ,Cohort ,Tachycardia, Ventricular ,Cardiology ,Female ,Inherited disease ,business ,Anti-Arrhythmia Agents ,Follow-Up Studies ,medicine.drug - Abstract
Introduction and objectives Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited disease characterized by polymorphic or bidirectional ventricular arrhythmias (VA) triggered by physical or emotional stress in young people with a structurally normal heart. Beta-blockers are the cornerstone of treatment, while flecainide has recently been incorporated into the therapeutic arsenal. The aim of this study was to report our experience with this drug. Methods The cohort included 174 genotype-positive CPVT-patients from 7 families. We collected data from patients who were receiving flecainide and analyzed the indications, adverse effects and dosage, clinical events, VA and arrhythmic window during exercise testing, and implantable cardioverter-defibrillator (ICD) shocks during follow-up. Results Eighteen patients (10.4%) received flecainide; 17 patients in combination with beta-blockers, and 1 patient as monotherapy due to beta-blocker intolerance. None of the patients presented side effects. In 13 patients (72.2%) the indication was the persistence of exercise-induced VA and in 5 patients (27.7%) persistent ICD-shocks, despite on beta-blockers. After flecainide initiation, the exercise-induced VA quantitative score was reduced by more than 50% in 66.7% of the members of family 1 (32.76 ± 84.06 vs 74.38 ± 153.86; P = .018). The arrhythmic window was reduced (5.8 ± 11.9 bpm vs 19.69 ± 21.27 bpm; P = .007), and 4 of 5 patients with appropriate ICD shocks experienced no further shocks in the follow-up. Conclusions In CPVT-patients flecainide reduces clinical events, exercise-induced VA, the arrhythmic window, and ICD shocks, with good tolerance.
- Published
- 2018
- Full Text
- View/download PDF
5. Obesity Surgery Score (OSS) for Prioritization in the Bariatric Surgery Waiting List: a Need of Public Health Systems and a Literature Review
- Author
-
Joaquín Marchena Gómez, Jaime Ponce, Francisco Cruz Benavides, Carlos Fernández Quesada, José Antonio Casimiro Pérez, Pedro de Pablos Velasco, Iván Arteaga González, and María del Val Groba Marco
- Subjects
Waiting time ,Prioritization ,medicine.medical_specialty ,Waiting Lists ,Endocrinology, Diabetes and Metabolism ,Bariatric Surgery ,030209 endocrinology & metabolism ,Severity of Illness Index ,03 medical and health sciences ,0302 clinical medicine ,Humans ,Medicine ,030212 general & internal medicine ,Nutrition and Dietetics ,business.industry ,Public health ,Obesity Surgery ,medicine.disease ,Obesity ,Obesity, Morbid ,Surgery ,Homogeneous ,Waiting list ,business ,Body mass index - Abstract
In the last decades, we have experienced an increase in the prevalence of obesity in western countries with a higher demand for bariatric surgery and consequently prolonged waiting times. Currently, in many public hospitals, the only criterion that establishes priority for bariatric surgery is waiting time regardless of obesity severity. We propose a new, simple, and homogeneous clinical prioritization system, the Obesity Surgery Score (OSS), which takes into account simultaneously and equitably the time on surgical waiting list and the obesity severity based on three variables: body mass index, obesity-related comorbidities, and functional limitations. We have reviewed the current literature related to obesity clinical staging systems, and we have carried out an analysis of our patients in waiting list and divided their characteristics according to their degree of severity (A, B, or C) in the OSS. Patients with OSS grade C have a higher mean BMI, greater severity in comorbidities, and greater socio-labor impact. The current surgery waiting time of our series is of 26 months. Currently, 27 patients (51.9%) with OSS grade B and 15 patients (51.7%) with OSS grade C have been on our waiting list for more than 1 year. Since the obesity severity, the waiting time and its clinical consequences are associated with an increase in morbidity and mortality, it is important to apply a structured prioritization system for bariatric surgery waiting list. This allows prioritization of patients at greater risk, improves patient prognosis, and optimizes costs and available health resources.
- Published
- 2018
- Full Text
- View/download PDF
6. Tratamiento de la hipercolesterolemia con inhibidores de la PCSK9 en receptores de trasplante cardiaco: primera experiencia en España
- Author
-
María del Val Groba-Marco, Gonzalo Barge-Caballero, Eduardo Barge-Caballero, María G. Crespo-Leiro, Samuel Del Castillo-García, and David Couto-Mallón
- Subjects
medicine.medical_specialty ,medicine.medical_treatment ,Injections, Subcutaneous ,Hypercholesterolemia ,MEDLINE ,Heart transplantation ,Antibodies, Monoclonal, Humanized ,chemistry.chemical_compound ,Antibodies, monoclonal, humanized ,Pharmacotherapy ,Ezetimibe ,Internal medicine ,medicine ,Humans ,PCSK9 Inhibitors ,Triglycerides ,Aged ,Transplant recipients ,biology ,business.industry ,Cholesterol ,Anticholesteremic Agents ,Cholesterol, HDL ,General Medicine ,Cholesterol, LDL ,Middle Aged ,Transplant Recipients ,Treatment Outcome ,chemistry ,Spain ,Monoclonal ,biology.protein ,Heart Transplantation ,Drug Therapy, Combination ,Antibody ,Proprotein Convertase 9 ,business ,Biomarkers ,medicine.drug - Abstract
Carta científica
- Published
- 2019
7. The Importance of Family-genetic Screening: The Phenotype Caused by the p.L3778F Ryanodine Receptor Mutation is Likely Less Severe Than Previously Thought
- Author
-
Juan Ramón Gimeno-Blanes, Fernando Benito-Bartolomé, Marcos García-Aguado, Irene García-Hernández, María del Val Groba-Marco, and Roberto Barriales-Villa
- Subjects
0301 basic medicine ,Genetics ,medicine.medical_specialty ,medicine.diagnostic_test ,business.industry ,Ryanodine receptor ,General Medicine ,030204 cardiovascular system & hematology ,Phenotype ,03 medical and health sciences ,chemistry.chemical_compound ,030104 developmental biology ,0302 clinical medicine ,Endocrinology ,chemistry ,Internal medicine ,Mutation (genetic algorithm) ,Medicine ,business ,DNA ,Genetic testing - Published
- 2016
- Full Text
- View/download PDF
8. EFICACY AND SAFETY OF FLECAINIDE TO REDUCE EXERCISE-INDUCED VENTRICULAR ARRHYTHMIAS AND THE ARRHYTHMIC WINDOW IN PATIENTS WITH CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA
- Author
-
María del Val Groba Marco, Josep Brugada, Eduardo Caballero Dorta, Luis Álvarez Acosta, Fernando Wangüemert Pérez, Guillermo J. Pérez, Ramon Brugada-Terradellas, Oscar Campuzano Larrea, and Julio Salvador Hernández Afonso
- Subjects
medicine.medical_specialty ,business.industry ,Emotional stress ,Catecholaminergic polymorphic ventricular tachycardia ,medicine.disease ,Internal medicine ,cardiovascular system ,medicine ,Cardiology ,In patient ,cardiovascular diseases ,Inherited disease ,Cardiology and Cardiovascular Medicine ,business ,Beta (finance) ,Flecainide ,Normal heart ,medicine.drug - Abstract
Background: Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited disease characterized by ventricular arrhythmias (VA) triggered in a situation of physical or emotional stress in young people with structurally normal heart. The cornerstone of the treatment are the beta
- Published
- 2017
- Full Text
- View/download PDF
9. [High prevalence of hypovitaminosis D in medical students in Gran Canaria, Canary Islands (Spain)]
- Author
-
Adela Soria López, Ana Mirallave-Pescador, María del Val Groba Marco, Sabrina García-Santana, Manuel Sosa Henríquez, Elisa González-Rodríguez, Pedro Saavedra, José Manuel Quesada Gómez, and Esther González-Padilla
- Subjects
Adult ,Male ,Pediatrics ,medicine.medical_specialty ,Students, Medical ,Bone density ,Population ,Parathyroid hormone ,Physical examination ,vitamin D deficiency ,Bone remodeling ,Young Adult ,Absorptiometry, Photon ,Bone Density ,Surveys and Questionnaires ,medicine ,Vitamin D and neurology ,Atlantic Islands ,Prevalence ,Humans ,education ,Calcifediol ,Ultrasonography ,Bone mineral ,education.field_of_study ,Lumbar Vertebrae ,medicine.diagnostic_test ,business.industry ,medicine.disease ,Vitamin D Deficiency ,Calcaneus ,Parathyroid Hormone ,Spain ,Female ,Bone Remodeling ,business ,Biomarkers - Abstract
Vitamin D deficiency has been described in many diseases and indeed in the general population. However fewer reports have been published in young and healthy people. Vitamin D deficiency should not be found in medical students of the Canary Islands, because they have all the resources to avoid it.To estimate the prevalence of vitamin D deficiency in a population of medical students of both gender from the University of Las Palmas de Gran Canaria.103 medical students of both genders from the University of Las Palmas de Gran Canaria. They completed a questionnaire and a physical examination. Vitamin D (25- hydroxycholecalciferol [25-HCC]), parathyroid hormone, biochemical markers of bone remodeling and a general biochemical study were performed. Bone mineral density was assessed by dual energy X-ray absorptiometry at the lumbar spine and the proximal femur. Quantitative ultrasounds parameters were measured at the calcaneus.Only 38.8% of the students of Medicine (42.1% of males and 44.9% of females) have 25-HCC values higher than 30 ng/dl as widely recommended nowadays. Vitamin D deficiency (20 ng/ml) is observed in 32.6% and vitamin D insufficiency (30 ng/ml) in 28.6% of the students of Medicine in Las Palmas de Gran Canaria.Although they have optimal conditions for having good levels of vitamin D, near two thirds of the medical students in the Canaries have low values of vitamin D.
- Published
- 2010
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.